Clinical Trial Update: Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial [Phase 3]

View source ↗

Summary

A multicenter, prospective, randomized Phase 3 trial evaluating infliximab for Kawasaki disease patients resistant to IVIG has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Fudan University | Conditions: Kawasaki Disease | Phase 3 | Status: COMPLETED